These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17536225)

  • 1. Circadian blood pressure variation and antihypertensive medication adjustment in normoalbuminuric type 2 diabetes patients.
    Czupryniak L; Pawłowski M; Saryusz-Wolska M; Loba J
    Kidney Blood Press Res; 2007; 30(3):182-6. PubMed ID: 17536225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation of office blood pressure and 24-hour ambulatory measurements in hypertensive patients - comparison between non-pharmacological treatment and antihypertensive medication.
    Dzien A; Pfeiffer K; Dzien-Bischinger C; Hoppichler F; Lechleitner M
    Eur J Med Res; 2000 Jun; 5(6):268-72. PubMed ID: 10882643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus.
    Anan F; Masaki T; Fukunaga N; Teshima Y; Iwao T; Kaneda K; Umeno Y; Okada K; Wakasugi K; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
    Eur J Clin Invest; 2007 Sep; 37(9):709-14. PubMed ID: 17696960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension.
    Fagard RH; Thijs L; Staessen JA; Clement DL; De Buyzere ML; De Bacquer DA
    J Hum Hypertens; 2009 Oct; 23(10):645-53. PubMed ID: 19225527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
    Astrup AS; Nielsen FS; Rossing P; Ali S; Kastrup J; Smidt UM; Parving HH
    J Hypertens; 2007 Dec; 25(12):2479-85. PubMed ID: 17984670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
    Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A;
    J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of the ADVANCE study for clinical practice.
    Zannad F
    J Hypertens Suppl; 2008 Sep; 26(3):S29-32. PubMed ID: 19363850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.
    Du X; Ninomiya T; de Galan B; Abadir E; Chalmers J; Pillai A; Woodward M; Cooper M; Harrap S; Hamet P; Poulter N; Lip GY; Patel A;
    Eur Heart J; 2009 May; 30(9):1128-35. PubMed ID: 19282274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypotensive and metabolic effect of indapamide and perindopril in patients with type 2 diabetes and arterial hypertensia].
    Askerov MM
    Georgian Med News; 2009 Apr; (169):44-8. PubMed ID: 19430043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal blood pressure circadian rhythm in acute ischaemic stroke: are lacunar strokes really different?
    Castilla-Guerra L; Espino-Montoro A; Fernández-Moreno MC; López-Chozas JM
    Int J Stroke; 2009 Aug; 4(4):257-61. PubMed ID: 19689751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
    Dolan E; Stanton AV; Thom S; Caulfield M; Atkins N; McInnes G; Collier D; Dicker P; O'Brien E;
    J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
    Jarmuzewska EA; Rocchi R; Guidoni A; Mangoni AA
    Panminerva Med; 2008 Sep; 50(3):207-16. PubMed ID: 18927524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study.
    Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Donner K; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Kontula K; Hiltunen TP
    J Hypertens; 2008 Jun; 26(6):1250-6. PubMed ID: 18475165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes.
    Puig JG; Marre M; Kokot F; Fernandez M; Jermendy G; Opie L; Moyseev V; Scheen A; Ionescu-Tirgoviste C; Saldanha MH; Halabe A; Williams B; Mion D; Ruiz M; Hermansen K; Tuomilehto J; Finizola B; Gallois Y; Amouyel P; Ollivier JP; Asmar R
    Am J Hypertens; 2007 Jan; 20(1):90-7. PubMed ID: 17198918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.
    Kearney-Schwartz A; Virion JM; Stoltz JF; Drouin P; Zannad F
    Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study.
    Katayama S; Kawamori R; Iwamoto Y; Saito I; Kuramoto K;
    Hypertens Res; 2008 Aug; 31(8):1499-508. PubMed ID: 18971523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocturnal blood pressure fall and metabolic syndrome score in hypertensive patients.
    Vyssoulis GP; Karpanou EA; Kyvelou SM; Adamopoulos DN; Deligeorgis AD; Spanos PG; Pietri PG; Cokkinos DF; Stefanadis CI
    Blood Press Monit; 2007 Dec; 12(6):351-6. PubMed ID: 18004102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.